Immune checkpoint inhibitor‐induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy—A multicentre analysis

Routine lipase monitoring was conducted in all participating centres, although not recommended in respective guidelines. Elevation of serum lipase was observed more frequently than recently reported. Although radiographic findings indicating pancreatitis were rare in asymptomatic patients, ICI treatment was frequently paused or discontinued and systemic steroids were administered. To reduce the existing uncertainty in routine clinical practice reflected by our findings, we provide an algorithm to guide the monitoring and management of potential pancreatic adverse events. Lipase measurement should be limited to symptomatic patients and/or those with radiographic findings indicative of pancreatic injury.

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2024-11-20
DOI
https://doi.org/10.1111/jdv.20384
Citations
3
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune checkpoint inhibitor‐induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy—A multicentre analysis

Kim A. Reiss, Wolfgang Hitzl, Erika Richtig, Florian Froehlich et al.
3 citations
Journal of the European Academy of Dermatology and Venereology
Cancer Immunotherapy and Biomarkers
0.85
article

Immune checkpoint inhibitor‐induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy—A multicentre analysis

Kim A. Reiss, Wolfgang Hitzl, Erika Richtig, Florian Froehlich, Magdalena Hoellwerth, Matthias Brandlmaier, T. Silly, Peter Koelblinger, M Bárta, Christoph Höeller, Bernhard Lange‐Asschenfeldt, M. Schmid‐Simbeck, Lukas Koch, Reinhard Dummer, L. Muigg
article en
3 citations

Abstract

Routine lipase monitoring was conducted in all participating centres, although not recommended in respective guidelines. Elevation of serum lipase was observed more frequently than recently reported. Although radiographic findings indicating pancreatitis were rare in asymptomatic patients, ICI treatment was frequently paused or discontinued and systemic steroids were administered. To reduce the existing uncertainty in routine clinical practice reflected by our findings, we provide an algorithm to guide the monitoring and management of potential pancreatic adverse events. Lipase measurement should be limited to symptomatic patients and/or those with radiographic findings indicative of pancreatic injury.

Journal of the European Academy of Dermatology and VenereologyVol. 39(9)
Paracelsus Medical University (AT), Donauspital (AT), Fachhochschule Wiener Neustadt (AT), Klinikum Klagenfurt (AT), University Hospital of Zurich (CH), Klinikum Wels-Grieskirchen (AT), Medical University of Vienna (AT)
Good health and well-being
Openalex Percentile: Top 22%
Cancer Immunotherapy and Biomarkers
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.